Portfolio Companies 2026 for Aisling Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Aisling Capital accounts for 10 tracked companies with verified cap-table data, 10 of which disclose round sizes totalling $2.5B. The median disclosed raise is $150M, and the largest is Treeline Biosciences at $1.1B, ahead of Talaris Therapeutics ($365M) and Nuvation Bio ($275M).
The names that recur most often on these portfolio cap tables are Aisling Capital (10 companies), Rock Springs Capital (3 companies), Surveyor Capital (3 companies), Omega Funds (3 companies), OrbiMed (2 companies), Casdin Capital (2 companies). By latest disclosed round, the market skews Series A (3), Other Equity (2), Series B (2), Growth (1).
Companies tracked: 10
Disclosed funding total: $2.5B across 10 companies
Median disclosed raise: $150M
Largest raise: Treeline Biosciences — $1.1B
Stage mix: Series A 3 · Other Equity 2 · Series B 2 · Growth 1
